Studium Genetics exhibited at the 7th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS), Rome, 21-25 June 2023. Download the Studium Genetics brochure presented at the congress.
“Three researchers from the University of Bologna have developed a technology that enables early diagnosis of oral cancer. A noninvasive and painless system that also has potential applications related to prognosis and follow-up with a strong social impact. – Forbes, Italian edition, August 2022 Great advances in personalized medicine are revolutionizing the approach to the patient. In particular, the development of next-generation drugs, methods of early diagnosis, correct prognosis, prediction of efficacy, and personalized therapy represent a new frontier in medicine. Oral carcinoma remains one of the most aggressive cancers worldwide, with a 50% mortality rate within the first 5 years…